Colorectal Carcinoma — Trials

Colorectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,010 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 344
Recruiting: 194
Ph III recruiting: 12
Growth YoY: +2.3%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (127)

clinicaltrialsPublishedShowing 301–322 of 322 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00785122	IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)(IMA910-101)	completed	Phase 1 / Phase 2	92	Immatics Biotechnologies GmbHINDUSTRY	9	May 16, 2013	clinicaltrials
NCT00707889	Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer	completed	Phase 2	159	AbbVie (prior sponsor, Abbott)